127 related articles for article (PubMed ID: 1626617)
1. c-myc oncogene copy number in squamous carcinoma of the head and neck.
Haughey BH; von Hoff DD; Windle BE; Wahl GM; Mock PM
Am J Otolaryngol; 1992; 13(3):168-71. PubMed ID: 1626617
[TBL] [Abstract][Full Text] [Related]
2. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray analysis of C-MYC oncogene copy number changes in larynx carcinoma.
Koynova DK; Tsenova VS; Toncheva DI
ORL J Otorhinolaryngol Relat Spec; 2005; 67(2):92-5. PubMed ID: 15821351
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of C-myc oncogenic activity in head and neck squamous cell carcinoma.
Mastronikolis N; Ragos V; Kyrodimos E; Chrysovergis A; Papanikolaou V; Mastronikolis S; Stamatelopoulos A; Tsiambas E
J BUON; 2019; 24(6):2242-2244. PubMed ID: 31983089
[TBL] [Abstract][Full Text] [Related]
6. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
Volling P; Jungehülsing M; Tesch H; Stennert E
Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
[TBL] [Abstract][Full Text] [Related]
7. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients.
Bhattacharya N; Roy A; Roy B; Roychoudhury S; Panda CK
J Oral Pathol Med; 2009 Nov; 38(10):759-63. PubMed ID: 19453846
[TBL] [Abstract][Full Text] [Related]
8. [Amplification of C-myc oncogene in squamous cell carcinoma of the larynx].
Liu S; Lin D; Hong B; Huang G
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):41-4. PubMed ID: 8070770
[TBL] [Abstract][Full Text] [Related]
9. Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
Leonard JH; Kearsley JH; Chenevix-Trench G; Hayward NK
Int J Cancer; 1991 Jun; 48(4):511-5. PubMed ID: 2045198
[TBL] [Abstract][Full Text] [Related]
10. MYC amplification in squamous cell carcinomas of the head and neck.
Rodrigo JP; Lazo PS; Ramos S; Alvarez I; Suárez C
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):504-7. PubMed ID: 8615967
[TBL] [Abstract][Full Text] [Related]
11. Approximately 580 Kb surrounding the MYC gene is amplified in head and neck squamous cell carcinoma of Indian patients.
Bhattacharya N; Sabbir MG; Roy A; Dam A; Roychoudhury S; Panda CK
Pathol Res Pract; 2005; 201(10):691-7. PubMed ID: 16325511
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
13. Oncogene amplification in squamous cell carcinoma of the head and neck.
Merritt WD; Weissler MC; Turk BF; Gilmer TM
Arch Otolaryngol Head Neck Surg; 1990 Dec; 116(12):1394-8. PubMed ID: 2248738
[TBL] [Abstract][Full Text] [Related]
14. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations in head and neck squamous cell carcinoma.
Bron L; Monnier P
Clin Otolaryngol Allied Sci; 1995 Aug; 20(4):291-8. PubMed ID: 8548956
[No Abstract] [Full Text] [Related]
16. Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.
Yin XY; Donovan-Peluso M; Whiteside TL; Johnson JT; Day R; Herberman RB; Locker J
Genes Chromosomes Cancer; 1991 Nov; 3(6):443-54. PubMed ID: 1777414
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
[TBL] [Abstract][Full Text] [Related]
18. CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas.
de la Guardia C; Casiano CA; Trinidad-Pinedo J; Báez A
Head Neck; 2001 Feb; 23(2):104-12. PubMed ID: 11303627
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
[TBL] [Abstract][Full Text] [Related]
20. Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma.
Brauswetter D; Dános K; Gurbi B; Félegyházi ÉF; Birtalan E; Meggyesházi N; Krenács T; Tamás L; Peták I
Virchows Arch; 2016 May; 468(5):579-87. PubMed ID: 26832731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
